COMPANY NEWS


BSE Code ISIN Demat Book Value (₹) NSE Symbol Div & Yield % Market Cap ( Cr.) P/E * EPS * Face Value (₹)
* Profit to Earning Ratio
* Earning Per Share
Dishman Pharmaceuticals and Chemicals provides update on scheme of merger Back
(12 Jul 2017)
Dishman Pharmaceuticals and Chemicals announced that pursuant to merger, the Company has been merged into CAIL and subsequently, in terms of the said Scheme, the name of Transferee Company i.e. Carbogen Amcis (India) has been changed to 'Dishman Carbogen Amcis' ("DCAL") w.e.f. 27 March, 2017.

Pursuant to the merger of DPCL into DCAL, securities of DPCL have been suspended by both BSE and NSE w.e.f. 30 May 2017 due to procedural reasons. The Company is in the process of listing the merged entity, DCAL on BSE and NSE.

Since the merged entity, DCAL is currently unlisted the Company is unable to file quarterly compliances as per SEBI (LODR) Regulations, 2015 with the Stock Exchanges for the quarter ended 30 June 2017.